Pliant Therapeutics, Inc. (NASDAQ: PLRX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT PLIANT THERAPEUTICS, INC.

Pliant Therapeutics, Inc. (NASDAQ: PLRX)
Listen to this Section


$1.17
-0.0150 ( -1.27% ) 225.5K

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Market Data


Open $1.17
Previous Close $1.18
Volume 225.5K
Market Cap $73.07M
Day Range $1.17 - $1.21
52 Week Range $1.09 - $1.95
Shares Outstanding 61.92M
Change % -1.27%
Net Change ▼ -0.0150
Insider Ownership N/A
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -550,192.00

Date Type Amount Purchased Purchaser
2024-07-12 Sale -10911.00 Cummings Keith Lamont
2024-07-12 Sale -38710.00 Coulie Bernard
2024-07-12 Sale -12319.00 Lefebvre Eric
2024-07-12 Sale -7656.00 Ouimette Mike
2024-07-12 Sale -9900.00 Hull Hans
2024-07-11 Sale -21313.00 Cummings Keith Lamont
2024-07-11 Sale -19337.00 Hull Hans
2024-07-11 Sale -24063.00 Lefebvre Eric
2024-07-11 Sale -75625.00 Coulie Bernard
2024-07-11 Sale -14954.00 Ouimette Mike

SEC Filings


Form Type Description Pages Date
4 Insider transactions 2 Jun 09, 2025
4 Insider transactions 2 Jun 09, 2025
4 Insider transactions 2 Jun 09, 2025
4 Insider transactions 2 Jun 09, 2025
4 Insider transactions 2 Jun 09, 2025
4 Insider transactions 1 Jun 09, 2025

Latest News


× Before browsing our site, please accept our cookies policy